Magnesium for the prevention and treatment of acute mountain sickness

Clinical Science

Volumn 106, Issue 3, 2004, Pages 269-277

  Dumont, Lionel ^a   Lysakowski, Christopher ^a   Tramèr, Martin R ^a   Junod, Jean Daniel ^a   Mardirosoff, Chahé ^b   Tassonyi, Edömer ^a   Kayser, Bengt ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Savoie Clinic   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Altitude; Blood brain barrier; Cerebral oedema; Hypobaric hypoxia; Magnesium; Randomized controlled trial

Indexed keywords

MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO;

ALTITUDE DISEASE; ARTICLE; ATAXIA; CLIMBING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; HEADACHE; HUMAN; INTERMETHOD COMPARISON; NAUSEA; NORMAL HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SCORING SYSTEM; STUDENT T TEST;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ALTITUDE SICKNESS; CITRIC ACID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MAGNESIUM SULFATE; MALE; ORGANOMETALLIC COMPOUNDS;

EID: 1642302117     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030187     Document Type: Article

References (43)

1. 2+ of NMDA responses in spinal cord neurones. Nature (London) 309, 261-263
2. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A. and Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature (London) 307, 462-465
3. Iseri, L. T. and French, J. H. (1984) Magnesium: nature's physiologic calcium blocker. Am. Heart J. 108, 188-193
4. Kass, I. S., Cottrell, J. E. and Chambers, G. (1988) Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology 69, 710-715
5. Heath, D. L. and Vink, R. (1999) Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. J. Neurosurg. 90, 504-509
6. Heath, D. L. and Vink, R. (1999) Optimization of magnesium therapy after severe diffuse axonal brain injury in rats. J. Pharmacol. Exp. Ther. 288, 1311-1316
7. Feldman, Z., Gurevitch, B., Artru, A. A. et al. (1996) Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J. Neurosurg. 85, 131-137
8. Lucas, M. J., Leveno, K. J. and Cunningham, F. G. (1995) A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 333, 201-205
9. Chien, P. F., Khan, K. S. and Arnott, N. (1996) Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomised trials. Br. J. Obstet. Gynaecol. 103, 1085-1091
10. Belfort, M. A., Anthony, J., Saade, G. R. and Allen, Jr, J. C. (2003) A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N. Engl. J. Med. 348, 304-311
11. Nelson, K. B. and Grether, J. K. (1995) Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95, 263-269
12. Muir, K. W. and Lees, K. R. (1995) A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Ann. N.Y. Acad. Sci. 765, 315-316
13. Muir, K. W. and Lees, K. R. (1998) Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke 29, 918-923
14. Lampl, Y., Gilad, R., Geva, D., Eshel, Y. and Sadeh, M. (2001) Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin. Neuropharmacol. 24, 11-15
15. Vink, R., Nimmo, A. J. and Cernak, I. (2001) An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clin. Exp. Pharmacol. Physiol. 28, 919-921
16. Bradford, A. and Lees, K. (2000) Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial. Curr. Control Trials Cardiovasc. Med. 1, 184-190
17. Hackett, P. H. and Roach, R. C. (2001) High-altitude illness. N. Engl. J. Med. 345, 107-114
18. Dumont, L., Mardirosoff, C. and Tramèr, M. R. (2000) Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. Br. Med. J. 321, 267-272
19. Hackett, P. H. (1999) The cerebral etiology of high-altitude cerebral edema and acute mountain sickness. Wilderness Environ. Med. 10, 97-109
20. Morocz, I. A., Zientara, G. P., Gudbjartsson, H. et al. (2001) Volumetric quantification of brain swelling after hypobaric hypoxia exposure. Exp. Neurol. 168, 96-104
21. 2 deprivation in the central nervous system: on mechanisms of neuronal response, differential sensitivity and injury. Prog. Neurobiol. 40, 277-318
22. Lipton, S. A. and Rosenberg, P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613-622
23. Chen, C. H., Chen, A. C. and Liu, H. J. (1997) Involvement of nitric oxide and N-methyl-D-aspartate in acute hypoxic altitude convulsion in mice. Aviat. Space Environ. Med. 68, 296-299
24. Chen, X. Q. and Du, J. Z. (2000) Hypoxia influences enkephalin release in rats. NeuroReport 11, 1555-1557
25. Wang, D. and Kaur, C. (2000) Response of epiplexus cells associated with the choroid plexus in the lateral ventricles of adult rats to high altitude exposure. Neurosci. Lett. 285, 197-200
26. Xie, J., Lu, G. and Hou, Y. (1999) Role of excitatory amino acids in hypoxic preconditioning. Biol. Signals Recept. 8, 267-274
27. Roche, E. and Romero-Alvira, D. (1994) Role of oxygen free radicals in altitude-related disorders. Med. Hypotheses 42, 105-109
28. Krasney, J. A. (1994) A neurogenic basis for acute altitude illness. Med. Sci. Sports Exercise 26, 195-208
29. Dumont, L., Mardirosoff, C., Soto-Debeuf, G. and Tassonyi, E. (1999) Magnesium and acute mountain sickness. Aviat. Space Environ. Med. 70, 625
30. Lysakowski, C., Von Elm, E., Dumont, L. et al. (2004) Effect of magnesium, high altitude and acute mountain sickness on blood flow velocity in the middle cerebral artery. Clin. Sci. 106, 279-285
31. Roach, R. C., Bartsch, P., Oelz, O. and Hackett, P. H. (1993) The Lake Louise acute mountain sickness scoring system. In: Hypoxia and Molecular Medicine (Sutton, J. R., Houston, C. S. and Coates, G., eds.), pp. 272-274, Queen City Press, Burlington, VT
32. Maggiorini, M., Muller, A., Hofstetter, D., Bartsch, P. and Oelz, O. (1998) Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat. Space Environ. Med. 69, 1186-1192
33. Drummond, J. C., Piyash, P. M. and Kimbro, J. R. (2000) Neuroprotection failure in stroke. Lancet 356, 1032-1033
34. Gorelick, P. B. (2000) Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls? Lancet 355, 1925-1926
35. Severinghaus, J. W. (1995) Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J. Appl. Physiol. 79, 375-379
36. Lindberg, J. S., Zobitz, M. M., Poindexter, J. R. and Pak, C. Y. (1990) Magnesium bioavailability from magnesium citrate and magnesium oxide. J. Am. Coll. Nutr. 9, 48-55
37. Peikert, A., Wilimzig, C. and Kohne-Volland, R. (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16, 257-263
38. 2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 35, 135-143
39. Attias, J., Weisz, G., Almog, S. et al. (1994) Oral magnesium intake reduces permanent hearing loss induced by noise exposure. Am. J. Otolaryngol. 15, 26-32
40. Fuchs-Buder, T., Tramèr, M. R. and Tassonyi, E. (1997) Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J. Neurosurg. Anesthesiol. 9, 324-328
41. Fong, J., Gurewitsch, E. D., Volpe, L., Wagner, W. E., Gomillion, M. C. and August, P. (1995) Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. Obstet. Gynecol. 85, 444-448
42. Xu, F. and Severinghaus, J. W. (1998) Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema. J. Appl. Physiol. 85, 53-57
43. Begon, S., Pickering, G., Eschalier, A. and Dubray, C. (2002) Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology 96, 627-632